DAX23.168 -0,6%Est505.693 -0,7%MSCI World4.343 -0,1%Top 10 Crypto8,7000 -0,6%Nas21.879 +0,2%Bitcoin58.376 +0,5%Euro1,1514 ±0,0%Öl109,2 +9,0%Gold4.676 -1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Lufthansa 823212 NVIDIA 918422 SAP 716460 Deutsche Telekom 555750 Siemens Energy ENER6Y Allianz 840400 Microsoft 870747 Novo Nordisk A3EU6F BASF BASF11 Tesla A1CX3T Mercedes-Benz Group (ex Daimler) 710000 ExxonMobil 852549 Volkswagen (VW) vz. 766403 Siemens 723610
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach Trumps Iran-Rede: DAX geht leichter ins lange Wochenende -- Wall Street letztlich uneins -- Rheinmetall, Telekom, Intel, Tesla, Öl-Aktien, Micron, Pharmawerte, Airbus, Thales, OHB im Fokus
Top News
SpaceX drängt an die Börse - Elon Musk strebt anscheinend 2-Billionen-Dollar-Bewertung an SpaceX drängt an die Börse - Elon Musk strebt anscheinend 2-Billionen-Dollar-Bewertung an
Diversifikation mit Devisen: Wann sich ein Fremdwährungskonto lohnt Diversifikation mit Devisen: Wann sich ein Fremdwährungskonto lohnt
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Labcorp Aktie

Kaufen
Verkaufen
Labcorp Aktien-Sparplan
237,85 EUR +3,15 EUR +1,34 %
BMN
240,00 EUR +6,00 EUR +2,56 %
HAML
finanzen.net zero
Labcorp jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.19,59 Mrd. EUR

KGV23,99Div. Rendite1,15%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA40C39

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS5049221055

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolLH

Labcorp Aktien News

DatumMeistgelesen
PR NewswireNAMSA Announces Strategic Acquisition of Select Assets of the Early Development Medical Device Testing Business of Labcorp
PR NewswireLabcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
PR NewswireLabcorp Appoints Victor Bulto to Board of Directors
Wer­bungLabcorp-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireLabcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research
PR NewswireLabcorp Announces 2025 Third Quarter Results
PR NewswireLabcorp to Offer First FDA-Cleared Blood Test to Rule out Alzheimer's-Related Amyloid Pathology in Primary Care Settings
PR NewswireLabcorp Declares Quarterly Dividend
PR NewswireLabcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
PR NewswireLabcorp to Announce Third Quarter Financial Results on October 28, 2025
PR NewswireLabcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
PR NewswireLabcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
PR NewswireLabcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease
PR NewswireLabcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
PR NewswireLabcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU
PR NewswireLabcorp Announces 2025 Second Quarter Results
PR NewswireLabcorp Declares Quarterly Dividend
PR NewswireLabcorp to Announce Second Quarter Financial Results on July 24, 2025
PR NewswireLabcorp Launches Labcorp Whole Health Solutions to Support Holistic Care
PR NewswireLabcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research
PR NewswireLabcorp to Webcast Its Annual Meeting of Shareholders May 15
PR NewswireLabcorp Announces 2025 First Quarter Results
PR NewswireLabcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
PR NewswireLabcorp Declares Quarterly Dividend
PR NewswireLabcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease
PR NewswireLabcorp to Announce First Quarter Financial Results on April 29, 2025
PR NewswireLabcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
PR NewswireLabcorp Announces Clinical Availability of Liquid Biopsy Test to Guide Personalized Treatment Plans for Patients with Advanced Solid Tumors
PR NewswireLabcorp Announces 2024 Fourth Quarter and Full Year Results
PR NewswireLabcorp to Speak at the 43rd Annual J.P. Morgan Healthcare Conference
PR NewswireLABCORP DECLARES QUARTERLY DIVIDEND
PR NewswireLabcorp to Announce Fourth Quarter Financial Results on February 6, 2025
PR NewswireLabcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
PR NewswireLabcorp CFO Glenn Eisenberg Announces Plans to Retire
PR NewswireLabcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test
PR NewswireLabcorp Declares Quarterly Dividend
PR NewswireLabcorp to Announce Third Quarter Financial Results on October 24, 2024
PR NewswireLabcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health
PR NewswireLabcorp to Speak at the Baird 2024 Global Healthcare Conference
PR NewswireLabcorp Finalizes Acquisition of Select Assets of Invitae
PR NewswireLabcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx

Labcorp News

Labcorp News: auf dieser Seite finden Sie alle Labcorp News und Nachrichten zur Labcorp Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Labcorp News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Labcorp News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.